However, the molecular mechanisms by which human RIPK3 deficiency underlies HSE do not involve an impairment of type I IFN-mediated antiviral immunity, contrasting with the situation in patients with HSE due to mutations of the TLR3-IFNAR1 circuit. The gene discussed is IFNAR1; the disease is herpes simplex encephalitis.